載入...
Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment
Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at advanced sta...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047046/ https://ncbi.nlm.nih.gov/pubmed/33854147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87525-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|